Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Clarity Pharmaceuticals logo — Clarity is developing next-generation products to address th...

Clarity Pharmaceuticals

Clarity is developing next-generation products to address the growing need for radiopharmaceuticals in oncology.

Founded 2010 Australia Australia 61 employees Series Unknown Total: $10.60M Biotechnology, Health Care +1

General Information

Company Name Clarity Pharmaceuticals
Founded Year 2010
Location Australia Australia +1
Founders / Decision Makers
Team member
Employees 61
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Clarity Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Clarity Pharmaceuticals

Clarity Pharmaceuticals is a clinical stage radiopharmaceutical company that aims to address the growing need for the use of radiopharmaceuticals in oncology. The company is a global leader in Targeted Copper Theranostics (TCT), developed with its proprietary SAR Technology platform. TCT is a next-generation disruptive platform in radiopharmaceuticals that employs the “perfect pairing” of copper-64 and copper-67 for diagnosis and therapy. Clarity's TCT products offer a compelling combination of high accuracy and high precision in the treatment of a range of cancers, as well as providing supply and logistical advantages over current theranostics. The company has a diverse range of products in clinical trials addressing both large indications such as prostate cancer and breast cancer, as well as small and orphan indications like neuroendocrine tumors (NETs) and neuroblastoma. Clarity's ultimate goal is to improve treatment outcomes for children and adults with cancer. Founded in 2010 and headquartered in Australia, Clarity Pharmaceuticals recently secured a $4.00M Venture Round investment on 29 June 2017. With its innovative approach to radiopharmaceuticals and a strong focus on addressing critical unmet needs in oncology, Clarity Pharmaceuticals presents an intriguing opportunity for potential investors looking to support advancements in cancer treatment.

Taxonomy: Radiopharmaceuticals, Oncology, Clinical stage, Theranostics, Copper-64, Copper-67, Cancer treatment, Clinical trials, Neuroendocrine tumors, Neuroblastoma, Antibody imaging, Peptide imaging, Companion diagnostics, Drug development, Nuclear medicine

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 29 Jun 2017
Grant •••••• - 18 Jul 2016
Venture Round •••••• 4
Investor Investor
•••• •••• 		24 May 2016
Grant •••••• - 01 Jan 2016
Venture Round •••••• 1
Investor
01 May 2014

View All 6 Funding Rounds

Clarity Pharmaceuticals Alternatives & Competitors

Clarity Pharmaceuticals vs
Radionetics Oncology
Radionetics Oncology United States

Discovering and developing novel radiotherapeutics for the treatment of cancer.

Series A
48 employees
Health Care, Health and Wellness
Compare Clarity Pharmaceuticals vs Radionetics Oncology
Clarity Pharmaceuticals vs
Race Oncology
Race Oncology Australia

Race Oncology (ASX: RAC) is an ASX-listed clinical stage, global biotechnology company.

14 employees
Pharmaceutical
Clarity Pharmaceuticals vs
Elixiron Immunotherapeutics
Elixiron Immunotherapeutics Taiwan

Transforming Immunotherapy with Precision

Undisclosed
18 employees
Biotechnology
Compare Clarity Pharmaceuticals vs Elixiron Immunotherapeutics
Also compare with: Clarity Pharmaceuticals vs Geneseeq Technology Inc. Geneseeq Technology Inc.

FAQ About Clarity Pharmaceuticals

Clarity is developing next-generation products to address the growing need for radiopharmaceuticals in oncology.
Clarity Pharmaceuticals was founded in 2010.
Clarity Pharmaceuticals is headquartered in Australia.
Clarity Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Clarity Pharmaceuticals has approximately 61 employees.
Clarity Pharmaceuticals has completed 6 funding rounds, raising a total of $10.60M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Clarity Pharmaceuticals include Radionetics Oncology, Race Oncology, Elixiron Immunotherapeutics, Geneseeq Technology Inc., Gene+. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Clarity Pharmaceuticals and Radionetics Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Clarity Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy